Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.575 USD | +0.59% |
|
+14.96% | +11.47% |
Jun. 26 | Oramed Pharmaceuticals Board Approves $20 Million Share-Buyback Program | MT |
Jun. 26 | Oramed Pharmaceuticals Inc. announces an Equity Buyback for $20 million worth of its shares. | CI |
Financials (USD)
Sales 2024 * | 750K | Sales 2025 * | 2M | Capitalization | 105M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | -14M | EV / Sales 2024 * | 139 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 52.3 x |
P/E ratio 2024 * |
-258
x | P/E ratio 2025 * |
-7.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.51% |
1 day | +0.59% | ||
1 week | +14.96% | ||
Current month | +0.19% | ||
1 month | +18.12% | ||
3 months | -8.04% | ||
6 months | +5.10% | ||
Current year | +11.47% |
![Extreme 2.5001](/images/extremecours_fleche.png)
![Extreme 2](/images/extremecours_fleche.png)
![Extreme 2](/images/extremecours_fleche.png)
![Extreme 1.67](/images/extremecours_fleche.png)
![Extreme 1.67](/images/extremecours_fleche.png)
![Extreme 1.67](/images/extremecours_fleche.png)
![Extreme 1.67](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 13-04-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 02-04-11 |
Miriam Kidron
FOU | Founder | 83 | 02-04-11 |
Leonard Sank
BRD | Director/Board Member | 59 | 07-10-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 2.575 | +0.59% | 81,427 |
24-07-01 | 2.56 | -0.39% | 131,941 |
24-06-28 | 2.57 | -4.10% | 93,789 |
24-06-27 | 2.68 | +4.28% | 231,937 |
24-06-26 | 2.57 | +14.73% | 1,364,421 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.47% | 105M | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+37.55% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- ORMP Stock